Estrogen increases survival in an orthotopic model of glioblastoma
- 393 Downloads
Despite the male preponderance for developing glial tumors and a body of published literature that suggests a female gender advantage for long term survival in both human and animal studies, there have been relatively few rigorous investigations into the hormonal effects on glial tumor growth. In a previous study, we concluded that estrogen played a major role in the female survival bias seen in an intracerebral nude rat model of glioblastoma multiforme. Here we explore the potential therapeutic effect of exogenous estradiol delivery in nude rats with orthotopic glioblastoma tumors and examine the mechanism of action of estradiol on reducing tumor growth in this animal model. We administered estradiol, in several dosing regimens, to male, female and ovariectomized nude rats in a survival study. Brain sections, taken at various time points in tumor progression, were analyzed for estrogen receptor protein, proliferative index and apoptotic index. Estradiol increased survival of male, female and ovariectomized nude rats with intracerebral U87MG tumors, in a gender specific manner. The estradiol mediated effect occurred early in tumor progression, and appeared to be caused in-part by an increase in apoptotic activity. It remains unclear if estradiol’s effect is direct or indirect and if it is estrogen receptor mediated. Estradiol-based or adjunctive therapy may be beneficial in treating GBM and further study is clearly warranted.
KeywordsGlioblastoma Estradiol Nude rat Gender Survival
The authors wish to thank Phyllis Spence and Rachel Heim for excellent technical assistance and Agniezska Lis Ph.D for helpful suggestions.
- 3.Plunkett R, Barone T, McCarthy B et al (1998) Influence of gender on survival of patients with glioma: analysis of the SEER database. J Neurooncol 39:272 AbstractGoogle Scholar
- 20.Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edn. Academic Press, San DiegoGoogle Scholar
- 30.Maggs JL, Morgan P, Park BK (1992) The sexually differentiated metabolism of [6, 7-3H]17ß-oestradiol in rats: male-specific 15α-and male-selective 16α-hydroxylation and female-selective catechol formation. J Steroid Biochem Mol Biol 42:65–76. doi: 10.1016/0960-0760(92)90012-8 CrossRefPubMedGoogle Scholar
- 32.Pardridge WM, Moeller TL, Mietus LJ, et al (1980) Blood-brain barrier transport and brain sequestration of steroid hormones. Am J Physiol 239 (Endocrinol Metab 2):E96–E102Google Scholar
- 33.Ball P, Haupt M, Knuppen R (1978) Comparative studies on the metabolism of oestradiol in the brain, the pituitary and the liver of the rat. Acta Endocrinol (Copenh) 87:1–11Google Scholar
- 41.Azcoitia I, Sierra A, Garcia-Segura LM (1999) Localization of estrogen receptor ß-immunoreactivity in astrocytes of the adult rat brain. Glia 26:260–267. doi: 10.1002/(SICI)1098-1136(199905)26:3<260::AID-GLIA7>3.0.CO;2-R CrossRefPubMedGoogle Scholar
- 48.Nakayama Y, Sakamoto H, Satoh K et al (2000) Tamoxifen and gonadal steroids inhibit colon cancer growth in association with inhibition of thymidylate synthase, survivin and telomerase expression through estrogen receptor beta mediated system. Cancer Lett 161(1):63–71. doi: 10.1016/S0304-3835(00)00600-5 CrossRefPubMedGoogle Scholar
- 58.Samaras V, Piperi C, Korkolopoulou P et al (2007) Application of the ELISPOT method for comapartive analysis of interleukin (IL)-6 and IL-10 secretion in peripheral blood of patients with astroglial tumors. Mol Cell Biochem 304(1–2):343–351. doi: 10.1007/s11010-007-9517-3 CrossRefPubMedGoogle Scholar